Rapid dynamics of the microtubule binding of ensconsin in vivo by unknown
INTRODUCTION 
Cells use microtubules (MTs) for intracellular transport,
mitotic division, cell motility and cellular morphogenesis.
Participation in such a variety of cellular activities involves
morphologically diverse MT arrays, including symmetric
radial arrays, mitotic spindles or polarized cytoplasmic arrays.
Markedly different MT polymerization dynamics are also
required for MT-based functions during interphase, compared
with mitosis (Saxton et al., 1984; Hamaguchi et al., 1985),
and during proliferation, compared with differentiation
(Mandelkow and Mandelkow, 1995). Disparate cell types
and activities may acquire the requisite morphologies and
dynamics of their MT arrays due to the action of non-tubulin
components such as MT-associated proteins (MAPs)
(Mandelkow and Mandelkow, 1995; McNally, 1999). MAPs,
proteins that bind along the length of MTs, but show neither
high affinity binding nor enzymatic activity for unpolymerized
tubulin, include MAPs of the tau, MAP1 and MAP2 families,
which are abundantly expressed in nervous tissue, and appear
to modulate MT properties there (Mandelkow and Mandelkow,
1995). 
That MAPs contribute to the disparities in dynamics and
functions of MTs in cells other than neurons is supported
by studies of vertebrate non-neuronal cells and tissues
(Cassimeris, 1999; Andersen, 2000), in which the most
abundant MAPs, MAP4 (Bulinski and Borisy, 1979; Parysek
et al., 1984), e-MAP (Suprenant et al., 1993; Lepley et al.,
1999), and ensconsin (E-MAP-115) (Bulinski and Borisy,
1979; Masson and Kreis, 1993), each appear to be functionally
distinct. MAP4 is a 210 kDa MAP that has been shown to
stabilize MTs and modulate their level in vivo (Olsen et al.,
1995; Nguyen et al., 1999). By contrast, e-MAP, a 77 kDa
MAP first isolated from echinoderm eggs (Suprenant et al.,
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Microtubule-associated proteins (MAPs) are proteins that
reversibly bind to and regulate microtubule dynamics and
functions in vivo. We examined the dynamics of binding of
a MAP called ensconsin (E-MAP-115) to microtubules in
vivo. We used 5×GFP-EMTB, a construct in which the
microtubule-binding domain of ensconsin (EMTB) is
fused to five copies of green fluorescent protein (GFP), as
a reporter molecule amenable to the use of fluorescent
speckle microscopy. Fluorescent speckle microscopy (FSM)
sequences and kymograph analyses showed rapid
dynamics of speckles comprised of 5×GFP-EMTB in
untreated cells. By contrast, in detergent-lysed
cytoskeletons, speckles were not dynamic. Since detergent-
lysed cytoskeletons differ from living cells in that they lack
both ATP and dynamic microtubules, we used azide
treatment to substantially reduce the level of ATP in living
cells and we used Taxol to halt microtubule dynamics. Both
treatments slowed the dynamics of 5×GFP-EMTB speckles
observed by FSM. We also used fluorescence recovery
after photobleaching (FRAP) to quantify the half-time of
binding and dissociation of the 5×GFP-EMTB chimera and
to compare this half-time to that of the full-length MAP
molecule. In untreated cells, the tg of either 5×GFP-EMTB
or full-length GFP-ensconsin was similarly rapid (~4
seconds), while in ATP-reduced and Taxol-treated cells, tg
was increased to 210 seconds and 40 seconds, respectively.
In detergent-extracted cells no recovery was seen.
Consistent with the rapid dynamics of 5×GFP-EMTB
measured with fluorescent speckle microscopy and FRAP,
we estimated that the affinity of the MAP for microtubules
is ~40 µM in untreated living cells, compared with ~1 µM
in vitro. However, KD,app was not significantly changed
in the presence of azide and was increased to 110 µM in
the presence of Taxol. To test whether changes in the
phosphorylation state of cellular proteins might be
responsible for altering the dynamics of ensconsin binding,
we used FSM to monitor staurosporine-treated cells.
Staurosporine treatment substantially halted dynamics of
5×GFP-EMTB speckles along MTs. Our results show that
ensconsin is highly dynamic in its association with
microtubules, and its microtubule association can be
altered by in vivo phosphorylation events.
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1993), has been shown to promote MT dynamic instability by
binding to MTs and decreasing their propensity to re-enter the
rescue phase during catastrophic depolymerization (Hamill et
al., 1998). Ensconsin, an 84 kDa protein expressed most
abundantly in epithelial tissue (Fabré-Jonca et al., 1998) does
not appear to modulate the dynamics of MTs in proliferating
cells under physiological conditions (Faire et al., 1999).
However, one property of ensconsin, namely, its tighter in vitro
binding to MTs in the presence of the MT-stabilizing drug,
Taxol (Bulinski and Bossler, 1994), distinguishes it from other
MAPs expressed in the same cell types.
Since different complements of MAPs are expressed at
different cell cycle stages and in different cell types, and since
MAPs differ in how they modulate the MTs to which they are
bound, one must understand how they bind to and dissociate
from MTs in vivo, and how their MT binding is regulated. The
in vivo association of some MAPs with MTs has been
addressed previously. For example, fluorescence recovery after
photobleaching (FRAP) studies showed that MAP2, a MAP
known to contribute to MT stability in vitro, had a half-time of
MT binding of roughly 5 minutes in neuronal cells (Scherson
et al., 1984). By contrast, Olmsted et al., performing similar
FRAP studies of MAP2 and also of MAP4, whose MT-binding
domains are very similar, found half-times of MT binding of
60 and 44 seconds, respectively, for the two MAPs (Olmsted
et al., 1989). In addition, the Olmsted group found evidence of
cell cycle regulation of both MAPs; in mitosis the half-times
measured were 14 and 17 seconds. A comparison of the rates
reported for MAP2 MT-binding dynamics by Scherson et al.
and Olmsted et al. suggested that cells regulate the affinity or
dynamics of this MAP in different cell types or under different
cell cycle conditions (Scherson et al., 1984; Olmsted et al.,
1989). Technical difficulties precluded quantification of MAP
behavior on individual MTs in the two previous studies of
MAP:MT dynamics, possibly limiting accuracy of tg data. 
Using fluorescent speckle microscopy (FSM) (Waterman-
Storer et al., 1998) to image green fluorescent protein (GFP)
chimeras of another MAP, CLIP-170, Perez et al. showed that
CLIP-170 binds exclusively to the ends of growing MTs in
vivo (Perez et al., 1999). Further, CLIP-170’s MT association
was found to be regulated such that the MAP dissociated
rapidly after subsequent growth of the MT. These data
provided clues about potential functions of CLIP-170, a MAP
that apparently does not function as a MT stabilizer.
In the current study, we examine the behavior of the MAP,
ensconsin, in vivo. Our interest in ensconsin was sparked by
several experimental results (Bulinski and Borisy, 1979;
Masson and Kreis, 1993). First, this MAP is cell-type-specific
or -selective; it is most prevalent in epithelial-derived cells,
such as differentiated cell types (Masson and Kreis, 1993;
Fabré-Jonca et al., 1999) or certain carcinoma cell lines
(Gruber et al., 2001). Second, ensconsin appears to bind at
uniform levels along the entire length of all cellular MTs,
associating concomitant with their polymerization (Faire et al.,
1999). At levels found on the MTs in undifferentiated
interphase cells, associated ensconsin does not affect MT
dynamics detectably (Faire et al., 1999). Finally, ensconsin
displays more tenacious in vitro binding to MTs in the presence
of Taxol (Bulinski and Bossler, 1994). These previous studies
suggest a MAP that rapidly associates with all MTs, yet is
unknown in its functions or the regulation of its MT binding.
Accordingly, we examined the affinity and dynamics of
nsconsin’s association with MTs in vivo, using both FSM and
FRAP techniques. Our results demonstrate that ensconsin is
highly dynamic in its association with MTs in living cells, with
a half-life of MT association of approximately 4 seconds. Our
data also demonstrate that reduction of cytoplasmic ATP
increases this half-life by at least two orders of magnitude,
indicating that cells can regulate ensconsin’s MT binding
dynamics. The MT-stabilizing drug, Taxol, also stabilized
ensconsin binding, altering the half-life of binding by an order
of magnitude. Our results have implications for possible




Except where noted, all tissue culture solutions and media were
purchased from Life Technologies Inc. (Bethesda, MD), and all
chemicals were obtained from Sigma Chemicals (St Louis, MO).
Plasticware and other materials were from Fisher Corporation
(Springville, NJ).
Cells and treatments 
African green monkey (TC-7) cells expressing 5×GFP-EMTB, a
construct in which the MT-binding domain of ensconsin (EMTB) is
fused to five copies of green fluorescent protein (GFP), and TC-7 cells
expressing GFP-Ensc, a construct encoding full-length ensconsin
conjugated to a single GFP, were prepared, characterized, and
maintained as described (Bulinski et al., 1999; Faire et al., 1999). In
some experiments, TC-7 cells stably expressing 5×GFP-EMTB and
GFP-Ensc were transiently transfected with pDS-red (Faire et al.,
1999), to provide a fluid phase marker for KD,appdeterminations. 
5×GFP-EMTB-TC-7 cells were detergent-extracted at 37°C in a
solution of 0.2 mg/ml saponin in PEM (80 mM PIPES, pH 6.9, 1
mM EGTA and 1 mM MgCl2) for 3 minutes, then the coverslip was
rinsed in PEM and mounted on a slide for microscopy. Other
treatments were performed on living cells grown on coverslips: Cells
were rinsed once and incubated at 37°C in Dulbecco’s phosphate-
buffered saline containing 5 mM sodium azide and 1 mM
deoxyglucose, to substantially reduce cellular level of ATP
(Wadsworth and Salmon, 1988). Cells were either imaged after 40-
120 minutes ATP-reduction or they were allowed to recover from a
60 minute ATP-reduction by rinsing once and incubating in normal
culture medium for 40-120 minutes before imaging. In other
experiments Taxol (1 µM, 120-160 minutes) or staurosporine (25 or
50 nM, 60-120 minutes) was added to normal culture medium prior
to imaging. 
Immunofluorescence was performed as described previously, with
rabbit antibodies to detyrosinated tubulin and rhodamine-conjugated
secondary antibody. Coverslips were mounted and sealed with
VALAP (rather than nail polish, in order to preserve GFP fluorescence
for dual wavelength photomicrographs, which were made within 2
days of fixation and staining). 
Imaging and calculations
Imaging of all TC-7-derived cells plated on glass coverslips was
performed as described (Waterman-Storer and Salmon, 1997; Faire et
al., 1999) on a heated microscope stage (37°C). For FSM analysis,
time-lapse images were collected with an Orca cooled CCD camera
(Hamamatsu Photonics, Bridgewater, NJ), and the resultant speckle
patterns were used to assess dynamics directly or through kymographs
(intensity of line scans over time; created with Metamorph software
from Universal Imaging, West Chester, PA). 
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Estimation of KD,app 
We estimated a value for KD,app using two methods. In the first, the
nocodazole-based approach, 5×GFP-EMTB-TC-7 cells were
microinjected with X-rhodamine tubulin, treated with nocodazole (10
µM, 12 hours) to depolymerize the MTs, and images were captured
in both GFP and rhodamine channels. We measured the protomer (that
is, fluorescence in an area ~1×2 µm in size that contained no MTs)
after the nocodazole treatment (before release) and after release, that
is, following wash-out of the nocodazole on the microscope stage
(Faire et al., 1999). MTs with associated 5×GFP-EMTB reformed
completely within 20 minutes, and images of both fluorophores were
taken. From these, we estimated the fraction of tubulin in the
unpolymerized (protomeric) state. Briefly, we measured the mean
intensity of rhodamine in regions of the lamellum clearly devoid of
microtubules, and we subtracted background. Measurement of the
same region of the cell during nocodazole treatment was used to
calculate the ratio of the intensities, to determine the proportion of
polymeric tubulin following recovery from drug treatment. The ratio
(protomerbefore:protomerafter) was 1.67 (n=1 cell, average of 5
intracellular locations). Since cell morphology did not change
appreciably during release from drug treatment, this ratio yields a
tubulin protomeric fraction of 1/1.67=0.6; corresponding to a
polymeric fraction of 0.4. In TC-7 cells, we calculated that the total
tubulin concentration is 20 µM, and the tubulin concentration within
MTs is 8 µM, corresponding to a concentration of ensconsin or EMTB
binding sites of 8 µM. To obtain this value, we calculated the amount
of non-nuclear protein per cell. Dividing by the approximate
cytoplasmic volume yielded a cytoplasmic protein concentration (e.g.
40 mg/ml). Next, the proportion of soluble protein that is tubulin (5%),
determined for TC-7 cells with or without transfected ensconsin
constructs (Gundersen et al., 1987; Faire et al., 1999) was used to
determine that tubulin=2 mg/ml in the cytoplasm. For analogous
calculations with similar results, see Larsson et al. (Larsson et al.,
1999). As described above for tubulin, we used the ratio of the
5×GFP-EMTB signal (before:after) drug release to determine that the
monomeric and MT-bound fractions of 5×GFP-EMTB were
1/1.86=0.54, and 0.46, respectively. The equilibrium dissociation
constant, KD, is given by
where [A] is the free concentration of 5×GFP-EMTB, [B] is the
concentration of available binding sites, and [AB] is the concentration
of MT-bound 5×GFP-EMTB. Using FSM images we determined that
expression was within the speckle limit (i.e. sufficiently low
expression to yield speckles rather than continuous labeling). Thus,
[B] is approximately equal to the total binding site concentration
([B]total=[AB]+[B]~=[B]). Additionally, we assumed that virtually all
polymerized tubulin molecules are available for binding, because
crowding-induced sub-stoichiometric binding would not occur when
this low density of 5×GFP-EMTB is present, and there are no known
competitors for the 5×GFP-EMTB binding site. Therefore, for the cell
analyzed by the nocodazole-based approach, the KD,appwas calculated
from
We also calculated KD,app with a volume marker-based approach, in
which cells were transfected with DS-red, a volume marker. Because
these cells were not injected with tubulin, the 8 µM figure derived
above was used in calculating the binding site concentration. As
above, background was subtracted and regions devoid of microtubules
were identified for analysis. The mean intensity of the volume marker
and of 5×GFP-EMTB in a chosen region ~1×2 µm in size (Fig. 4)
were measured and their ratio calculated. This ratio, which was
constant in all regions of the cell that were devoid of MTs, was used
to scale the volume marker to free 5×GFP-EMTB signal. The scaled
volume marker image was subtracted from the total 5×GFP-EMTB
image, leaving an image that was, ideally, proportional to the
concentration of MT-bound 5×GFP-EMTB. A broad region of the
lamellum was then identified and the mean intensities of total and
bound 5×GFP-EMTB signal were measured. The ratio, total
EMTB:bound EMTB, was used to calculate the fraction bound, the
fraction free, and the KD,app value, as described above. Two regions
were analyzed per cell in each of five cells; results differed by <10%
within all cells analyzed.
Measurements of KD,app in azide- and Taxol-treated cells were made
as above, but using MT polymer concentration values of 14 µM and
20 µM, commensurate with previous measurements of TC-7 cells
subjected to these MT-stabilizing treatments (Gundersen et al., 1987)
(data not shown).
Microscopy and laser photobleaching
For FRAP analyses, cells expressing 5×GFP-EMTB were grown on
coverslips, placed in a modified Rose chamber, and imaged with a
Nikon TE300 inverted microscope equipped with an Orca 1 cooled
CCD camera and controlled by MetaMorph imaging software (Faire
et al., 1999). Images were obtained using a 100×/1.4 NA Plan Apo
Phase 3 objective, a 100 W mercury arc fluorescent light source
(attenuated to ~10%), and a Chroma Hy-Q FITC filter set.
Photobleaching experiments were performed essentially as described
(Maddox et al., 2000). Briefly, a 488 nm line from an argon laser
(Spectra-Physics, Mountain View, CA) was selected through a band-
pass filter and shuttered to control exposure. The laser was passed
through a beam expander and focused onto the field diaphragm as a
spot conjugate to a diameter at half-maximal intensity of 0.8 µm at
the specimen plane (Maddox et al., 2000). For the experiments shown
in Table 1, the laser was intentionally de-focused to illuminate and
bleach a spot sufficiently large (≥three times larger diameter) to allow
separate analysis of FRAP in the edge and middle regions of the
bleached spot. 
Cells were imaged before and after bleaching. In general, a region
on a single MT was bleached, and following recovery, some MTs were
bleached and allowed to recover as many as 10 times in the same spot.
Images were collected before (≥30 seconds) and after (≥10 minutes)
bleaching, at time intervals of either 1 image per second or by
‘streaming’, that is, four images collected per second without shutter
closure. Exposure times were 100-250 ms in all cases. Cellular
background was subtracted from these data, and the decay of
fluorescence (photobleaching) over the same time period in an
unbleached portion of the same MT that had been bleached by the
laser was fitted with an exponential decay curve [(F(t)=F0(e–kt)], in
which F(t) is the fluorescence at any time, F0 is the initial fluorescence,
and k is the fluorescence decay constant. Decay-corrected MT
fluorescence was plotted against time of recovery and fitted to an
exponential recovery curve: F = Finf – ((Finf – Fblch)(e–kOFF(t))) in which
Fblch is the fluorescence at the time of bleaching, and Finf is the
fluorescence at t=infinity (that is, fluorescence completely recovered).
This equation, whose derivation is described completely in Appendix
1, was used to determine koff. The tg was calculated as ln(2)/kOFFand
% recovery was calculated as: [(Finf – Fblch) / (Fprebleach – Fblch)] × 100.
RESULTS
Dynamics of 5 ×GFP-EMTB speckles in living cells
In earlier studies of monkey cells stably expressing a low level
of chimeras consisting of several green fluorescent protein
(GFP) molecules attached to a single ensconsin MT-binding
domain (EMTB), we showed that these chimeras bound along










polymerization, and did not cause aberrant MT behaviors
(Faire et al., 1999). By several criteria, the GFP-EMTB
chimeras mimicked the MT-binding behavior of endogenous
ensconsin, making them faithful reporters for ensconsin’s MT-
binding dynamics in living cells (Faire et al., 1999; Bulinski et
al., 1999).
We also noted that the fluorescence of chimeras containing
four or five GFP molecules per EMTB molecule (4×GFP-
EMTB and 5×GFP-EMTB) appeared as discrete fluorescent
speckles, rather than continuous label, along MTs (Faire et al.,
1999; Bulinski et al., 1999). Accordingly, we made use of
fluorescent speckle microscopy (FSM) (Waterman-Storer et
al., 1998) to visualize the dynamics of 5×GFP-EMTB in living
cells, as shown in Fig. 1. The time series in Fig. 1a, untreated
cells, shows speckles of various apparent sizes and intensities.
The fluorescent speckles arise from variation in the number of
fluorophores among the 222 nm resolvable regions along a MT;
each fluorophore emits the 510 nm green light characteristic of
GFP. Comparing speckle density along individual MTs with
the molar ratio we measured (5×GFP-EMTB:tubulin)
suggested that the tiniest speckles represent single molecules
of chimera, while the brighter speckles represent stochastically
clustered groups of three to five molecules (Bulinski et al.,
1999) (data not shown). Fig. 1a shows that the 5×GFP-EMTB
speckles are highly dynamic. In the example shown, only one
peckle present at the start of the time-lapse recording
remained in the same position 8 seconds later (Fig. 1a, white
arrow). By contrast, speckles at some positions disappeared
during the excerpted recording (Fig. 1a, white arrowhead),
while some speckles appeared de novo during the recording
(Fig. 1a, filled arrowhead). A kymograph made from analysis
of a single MT is shown in Fig. 1f. In this visual representation,
no obvious pattern of speckles can be observed over time,
suggesting that the MAP is highly dynamic in its association
with the MT. 
In contrast to its behavior in living cells, 5×GFP-EMTB
speckles in detergent-extracted cytoskeletons were not
dynamic, indicating a long-lived association of 5×GFP-EMTB
with the MT lattice. Numerous speckles remained in the same
relative position throughout the recording (marked by arrows
in the time-lapse micrographs, Fig. 1b); these appear as white
vertical stripes in the kymograph in Fig. 1g. That extraction
halted speckle dynamics was not surprising, since previous
experiments had demonstrated that ensconsin remains bound
to MTs in detergent-extracted cytoskeletons (Masson and
Kreis, 1993; Bulinski and Bossler, 1994). 
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Fig. 1.Dynamics of GFP-ensconsin chimera speckles in vivo. Fluorescent speckle microscopy (FSM) was used to record the dynamics of
5×GFP-EMTB chimeras in living cells and cytoskeletons. (a-e) Time-lapse micrographs of 5×GFP-EMTB speckles in living cells. Arrows
point to speckles that remain from one interval to the next, while arrowheads denote speckles that appear or disappear during th  sequence. The
bar in the right-hand corner of time-lapse series e shows the magnification of 1µm in all panels. (f-j) Kymographs of a single MT segment from
the time-lapse sequences. As shown, a and f are from untreated, b and g, are from detergent-extracted, c and h are from ATP-reduced, d and i
are from ATP-reduced and then recovered and e and j are from Taxol-treated cells. See Materials and Methods for details of the treatments.
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Detergent-extracted cytoskeletons differ from living cells in
two important features: they are depleted in ATP and soluble
proteins relative to living cells, and their MTs do not undergo
polymerization/depolymerization dynamics. We tested
whether cellular energy and/or MT polymerization dynamics
were required for MT-binding dynamics of 5×GFP-EMTB in
living cells. Wadsworth and Salmon demonstrated that
treatment of cells with sodium azide and deoxyglucose was
sufficient to deplete 70-90% of cellular ATP within 5-15
minutes, and to halt energy-requiring processes during mitosis
(Wadsworth and Salmon, 1988). 5×GFP-EMTB-TC-7 cells
treated with sodium azide and deoxyglucose for 40-120
minutes yielded speckle dynamics qualitatively similar to those
of extracted cells (compare Fig. 1c,h with Fig. 1b,g). Effects
of ATP-reduction were reversible; restoring ATP level by re-
feeding cells azide-free medium produced substantial speckle
dynamics once again (Fig. 1d,i). 
To test if speckle dynamics were altered by dampening MT
dynamics, we treated cells with Taxol (10 µM) (Liao et al.,
1995), which markedly slowed speckle dynamics (Fig. 1e,j,
note arrows in 1e), although less so than in ATP-reduced or
extracted cells. Some speckles in Taxol-treated cells still
appeared to be dynamic (note arrowhead in the first two panels
of Fig. 1e). Even though their mechanism of action is distinct
from that of Taxol, low concentrations of microtubule
depolymerizing drugs also dampen cellular MT dynamics,
ffectively by kinetically stabilizing the MTs (Jordan et al.,
1992; Liao et al., 1995). However, we saw no change in speckle
dynamics in cells treated with various concentrations of
nocodazole or vinblastine (10-200 nM), suggesting that MT
dynamics, per se, may not be involved in regulating speckle
dynamics. Instead, Taxol may specifically affect ensconsin’s
binding to the MT lattice via another mechanism. 
FRAP measurements of 5 ×GFP-EMTB
FSM analysis showed that speckles of 5×GFP-EMTB
exhibited a short dwell time at each position on the MT (Fig.
1a,f). Rapid speckle dynamics might result if the MAP
transiently associated with and dissociated from the MT.
Alternatively, speckles might actually move if 5×GFP-EMTB
molecules laterally diffuse along the surface of the MT,
perhaps owing to low binding affinity. We used fluorescence
recovery after photobleaching (FRAP) measurements to allow
us to quantify the tg of the MAP chimeras on the MT and to
use the pattern of FRAP to distinguish between the
dissociation/re-association and lateral diffusion models. As
shown in typical images in Fig. 2A, FRAP occurred very
rapidly along single MTs throughout the bleached region in
untreated cells. Fig. 2B shows fluorescence quantified along a
single MT that has been bleached twice; for each bleach the
Fig. 2.Photobleaching and recovery of ensconsin chimera in
untreated cells. (A) Time-lapse micrographs of the bleached area
before (pre-bleach) at the time of bleaching (laser spot) and at
intervals during the recovery. Elapsed time, in seconds, is shown in
each micrograph. (B) Corrected fluorescence (total pixel intensity
along a segment of a bleached MT) was plotted against time (in
seconds) before and after each of two bleach events. The time of
each bleach is marked with an arrow. Fluorescence shown has
been corrected, using an unbleached segment of an adjacent MT, for decay caused by photobleaching during time-lapse imaging and cellular
background has been subtracted. (C) Determination of kOFF. As described in Materials and Methods, the logarithm of the fraction of
fluorescence recovered was plotted against time and the slope, kOFF, was determined by linear regression.
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fluorescence was corrected for decay due to repeated
illumination, using an unbleached segment of MT, and cellular
background was subtracted. The graphs in Fig. 2C show the
kOFF determined from the data in Fig. 2B, using the equation
whose derivation is described in Appendix 1. Figs 2B and 2C
show that recovery was similar after each bleaching event.
As shown in Table 1, the tg of FRAP, ~4 seconds, was
indistinguishable for areas in the middle or at the edge of the
zone bleached by the laser; recovery was virtually complete in
both regions. The fact that we did not observe more rapid
recovery at the edge than at the middle of the bleached zone is
not consistent with a lateral diffusion mechanism. Instead,
these data strongly favor the dissociation/re-association model
for speckle dynamics. 
Next, we quantified the MT-binding dynamics of 5×GFP-
EMTB and full-length ensconsin labeled with a single GFP
(GFP-Ensc) (Faire et al., 1999), to determine if MT-binding
dynamics of both molecules were quantitatively similar. Our
concern was that in vivo dynamic behavior might be altered by
the exclusion of ~75% of the ensconsin sequence and/or the
inclusion of five appended GFP moieties in the 5×GFP-EMTB
chimera. As shown in Table 2, both molecules showed
equivalent FRAP behavior; each had a tg of ~4 seconds. This
result corroborated previous results that suggested that 5×GFP-
EMTB faithfully mimics in vivo and in vitro binding of the
full-length MAP (Bulinski et al., 1999). Thus, measuring the
dynamics of 5×GFP-EMTB is a valid model for the MT-
binding dynamics of full-length ensconsin. The fact that both
molecules show identical behavior upon detergent extraction
suggests that full-length ensconsin undergoes the same
changes in behavior as 5×GFP-EMTB during various
treatments. This result suggests that treatments that change
FSM speckle dynamics of 5×GFP-EMTB would effect similar
changes to the dynamics of full-length ensconsin.
Accordingly, we used FRAP to quantify changes in MT-
binding dynamics of 5×GFP-EMTB in cells that were
detergent-extracted or subjected to in vivo treatments. As
shown in the example in Fig. 3A, after bleaching MTs in
detergent-extracted cells we observed negligible FRAP,
corroborating the images of static speckles obtained in FSM
(Fig. 1C). Fig. 3B shows the corrected fluorescence of the
bleached MT; because there was no recovery (5.9±5.8%
r covery, on average), we did not attempt to calculate a tg from
these data (Table 2). In cells in which ATP was reduced by
incubation in azide-containing medium, dynamics were greatly
dampened compared with those of untreated cells (tg=209
seconds). However, in contrast to extracted cells, substantial
FRAP did occur in ATP-reduced cells. Note that ATP-
reduction was completely reversible (Table 2); FRAP
measurements of cells allowed to recover from ATP-reduction
were indistinguishable from those of untreated cells. 
Results of FRAP from Taxol-treated cells were significantly
different from those of untreated cells (Table 2), although the
difference was less striking than results from ATP-reduced
cells. Taxol-treatment increased the tg of binding tenfold over
untreated cells, to 39 seconds. We note that this change in t
occurred during a relatively short Taxol treatment (2 hours), in
which Taxol elicited neither mitotic entry nor cell cycle arrest. 
Affinity of 5 ×GFP-EMTB for MTs in vivo
The rapid dynamics of 5×GFP-EMTB measured via FSM and
FRAP suggested that the 5×GFP-EMTB molecule might bind
loosely to MTs in vivo. Further, we hypothesized that an
increase in affinity of the MAP is a possible mechanism by
which the residence time of the MAP could be increased in cells
treated with azide or with Taxol. To test this hypothesis, we used
a volume marker-based approach to estimate the dissociation
equilibrium constant, KD,app, under three different conditions
(untreated, ATP-reduced, and Taxol-treated (see Fig. 4 and
Materials and Methods for details). In untreated cells, KD,app
was estimated to be 44 µM (Table 3). This value, almost 30-
fold larger than the in vitro KD,app of full-length ensconsin
(KD=1.6 µM) (Bulinski and Bossler, 1994), is reasonable given
the rapid in vivo dynamics shown by FSM and FRAP (Fig.
1A,B; Fig. 2) (Table 1). However, we did not detect a significant
change in KD,app in azide-treated cells, and in Taxol-treated
cells, KD,app increased to 110 µM (Table 3). These results do
not support the hypothesis that treatment-induced alteration in
the MT residence time of ensconsin chimera can be attributed
to changes in ensconsin’s affinity for MTs. 
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Table 1. FRAP dynamics do not vary with position along the MT 
Ensconsin chimera MT area measured kOFF s−1* tg (s) % Recovery* n
5×GFP-EMTB Middle of bleached zone 0.163±0.122 4.26 86.4±28.8 4
5×GFP-EMTB Edge of bleached zone 0.189±0.105 3.67 82.6±26.2 5
*Values represent means±s.d. No s.d. is given for tg because it is calculated from measured values of kOFF. 
P=0.8 for comparisons of kOFF in the middle versus the edge of the bleached zone.
Table 2. FRAP dynamics vary with treatment conditions, not chimera used
MAP chimera Treatment condition kOFF s−1* tg (s) % Recovery P value‡ n
GFP-Ensc Untreated 0.20±0.09 3.56 87.8±37.9 1.0 4
5×GFP-EMTB Untreated 0.18±0.11 3.78 96.8±15.6 − 9
5×GFP-EMTB Detergent-extracted ND ND 5.9±5.8 ND 4
5×GFP-EMTB ATP-reduced 0.0033±0.0032 209 30.9±12.4 0.001 4
5×GFP-EMTB ATP-reduced & recovered 0.19±0.13 3.69 83.0±24.7 0.9 14
5×GFP-EMTB Taxol-treated 0.018±0.015 39.3 46.9±25.1 0.0005 8
*Values represent mean±s.d. No s.d. is given for tg because it is calculated from measured values of kOFF.
‡P values were determined by comparing values for kOFF for each treatment condition to values for untreated 5×GFP-EMTB (shown in row 2).
ND, values for kOFF and tg were not determined, since no fluorescence recovery was observed.
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Dynamics of 5 ×GFP-EMTB does not depend on
post-translational detyrosination of MTs
Alterations in either the MTs or in the MAP chimera, itself,
could be responsible for altering MAP:MT binding dynamics
in cells that were detergent-extracted, ATP-reduced, or Taxol-
treated. Changes in the MT lattice or MAP-binding sites could
alter the tg of ensconsin binding. One plausible, reversible
change in the MTs would be increased tubulin post-
translational modification. All three treatments have been
reported to increase the longevity of MTs. Since the
detyrosinating enzyme acts on the MT polymer, the longer life
of MTs in each treatment condition therefore increases their
level of tubulin post-translational detyrosination (Gundersen et
al., 1987). If ensconsin chimeras bound more stably to Glu
MTs, increasing the detyrosination of all cellular MTs would
increase the MT residence time of 5×GFP-EMTB.
To determine whether an increase in MTs enriched in
etyrosinated (Glu) MTs could account for altered binding
dynamics of ensconsin chimeras, we subjected 5×GFP-EMTB-
TC-7 cells to each treatment employed in FSM and FRAP
experiments, and immunostained them with anti-Glu tubulin
antibody. We visualized fluorescence of both GFP-EMTB and
Glu tubulin; as shown in Fig. 5 we determined that Glu MTs
comprised only a subset of MTs under all treatment conditions.
Fig. 3.Photobleaching and recovery of ensconsin chimera in detergent-extracted cells. (A) Time-lapse micrographs of the bleached area are
shown before (prebleach), at the time of bleaching (white circle, showing the position of the laser bleach, since no image was captured at the
instant of the bleach) and at intervals during the recovery. Elapsed time, in seconds, is shown in each micrograph. (B) Corrected fluores ence of
a bleached MT (pixel intensity) was plotted against time (in seconds) at intervals before and after bleaching. The time of the bleach is marked
with an arrow; fluorescence shown has been corrected, using an unbleached segment of an adjacent MT, for decay caused by photoblaching
during repeated illumination, and cellular background has been subtracted.
Table 3. Estimation of KD,app for 5×GFP-EMTB in vivo
KD,app KD,app(µM), KD,app(µM), ∆Goapp
Condition (µM)* upper 95% confidence limit‡ lower 95% confidence limit‡ (kBT) n§ P¶
Untreated 11 44 2.7 −11.4 5 −
ATP-reduced 34 170 6.6 −10.9 5 0.05
Taxol-treated 46 110 19 −10.9 5 0.005
*K D,appshown was estimated using the volume-marker approach described in Materials and Methods. Although only a single, untreated cell was analyzed
using the nocodazole-based approach, results were similar to those presented here; the latter method yielded a KD,appof 9.4 µM (see Materials and Methods for
details).
‡Errors in estimating concentrations of bound/free 5×GFP-EMTB necessarily yield errors in calculated KD,app. Therefore, rather than reporting s.d. for each
KD,appvalue, we report here the most extreme values for KD,appthat we calculated from 5×GFP-EMTB values, bound and free, using high and low values. Thus,
the 95% confidence limits were estimated by multiplying the s.d. of the ∆Goappestimates by 2, adding this energy to the mean ∆Goappto obtain the upper 95%
confidence limit in ∆Goapp, and subtracting this energy to get the lower 95% confidence limit in ∆Goapp. Note that KD,app(M) and ∆Goapp(kBT) are related
through ∆Goapp=ln KD, allowing us to calculate the upper and lower 95% confidence level of KD,app.
§All measurements were made in five separate cells; two areas per cell were measured, and the area of the centrosome was avoided. 
¶Probability that treatment values were the same as control, determined by two-tailed t-test assuming equal variance. Note that the increase in KD,appwith
Taxol is statistically significant, while the change with azide is borderline (P=0.05).
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Note that some increase in Glu MTs
occurred, especially in Taxol-treated
cells (compare Fig. 5a and 5g).
However, even after Taxol treatment,
numerous MTs in the array were not
enriched in Glu tubulin. In addition, we
noted that Glu MTs were no more
prevalent in extracted cells (Fig. 5c), on
which 5×GFP-EMTB showed the
greatest tg, than in ATP-reduced (Fig.
5e) or Taxol-treated cells (Fig. 5g); in
fact the converse appeared to be true.
Since FSM and FRAP dynamics were
altered on all MTs examined, but only
some MTs in treated cells were enriched
in Glu tubulin, altered binding of
5×GFP-EMTB to Glu MTs, compared
with their tyrosinated counterparts,
cannot explain the change in MT
binding dynamics of the MAP. Since
we are aware of no rapid, reversible
change in the MTs that alters all MTs
concomitant with each of the three
treatments, 5×GFP-EMTB’s altered
MT-binding dynamics most likely result
from a change in the MAP, itself, rather
than in the MT. 
Modification of MAP phosphoryl-
ation state might be expected in cells
that have been extracted, ATP-reduced
or Taxol-treated. However, other ATP-
requiring proteins, instead or in
addition, could be active in changing
ensconsin behavior. Other proteins have
been shown to be changed in their
phosphorylation state by Taxol (Wolfson
et al., 1997; Shtil et al., 1999;
Blagosklonny et al., 1999; Yujiri et al.,
1999; Stone and Chambers, 2000). To
test whether phosphorylation might
indeed play a role in ensconsin behavior,
we treated cells with staurosporine, a
general inhibitor of protein kinases. We
chose treatment conditions sufficient to
inhibit most cellular protein kinases
(Sauve et al., 1999) but insufficient to cause major cellular
damage such as induction of apoptosis (Desagher et al., 1999).
We analyzed speckle dynamics of 5×GFP-EMTB by FSM in
the presence of staurosporine. Fig. 6A shows time-lapse
images of a sample MT from a staurosporine-treated cell, and
Fig. 6D shows the corresponding kymograph. We noted that
5×GFP-EMTB speckles were markedly static on the MTs in
staurosporine-treated cell, in contrast to the dynamic speckles
seen on MTs in untreated cells (Fig. 6B). Speckles on MTs in
staurosporine-treated cells looked similar to those in ATP-
reduced cells (compare Fig. 6A and C), suggesting that FRAP
data from staurosporine-treated cells would also give results
similar to ATP-depleted cells. The ability of staurosporine
treatment to dampen the dynamics of 5×GFP-EMTB speckles
suggests that kinase activity is required for the rapid dynamics
of ensconsin’s association with MTs in vivo. Thus, alteration
in the phosphorylation state of the MAP chimera most readily
explains the alteration in MAP:MT dynamics we observed
during treatment with detergent, azide, or Taxol. 
DISCUSSION
In this paper, we documented extremely rapid dynamics of
ensconsin’s MT-binding (tg ~4 seconds). Our results show that
ensconsin’s dynamics are even more rapid than had been
inferred from previous data demonstrating that the MAP
associates and dissociates concomitant with the growth and
shrinkage of individual MTs (Faire et al., 1999). Our results
also demonstrate that ensconsin’s in vivo MT-binding
dynamics are at least tenfold more rapid than the figures of 60
seconds and 44 seconds that were reported for MAP4 and
JOURNAL OF CELL SCIENCE 114 (21)
Fig. 4.Measurement of bound and unbound 5×GFP-EMTB in living cells. In order to estimate
KD,app, we quantified 5×GFP-EMTB bound to MTs and 5×GFP-EMTB free in the cytoplasm.
Using soluble DS-red expressed in the same cells was used as a volume marker. As shown in
the figure, images of GFP and DS-red were captured from the same cell. Next, in each image,
the background fluorescence was subtracted from an area that contained MTs and regions free
of MTs (shown in box). To quantify unbound 5×GFP-EMTB, paired regions that were devoid
of microtubules were used to scale the DS-red image to obtain an image of unbound GFP. In
the example shown, regions used were ~1×2 µm in size. Bound 5×GFP-EMTB was calculated
as (Total GFP) − (Bound GFP). Bound and unbound 5×GFP-EMTB were used to calculate the
apparent dissociation constant, KD,app.
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MAP2, respectively (Olmsted et al., 1989) in a different line
of epithelial cells, and >100-fold more rapid than the figure of
~5 minutes that was reported for MAP2 in differentiated cells
(Scherson et al., 1984). Direct measurements of in vivo
dynamics of tau protein have not been reported, but Mercken
et al. used data showing that the axonal transport rate of tau
differed from the transport rate of other MT components to
suggest that tau may be slightly more dynamic in its in vivo
MT association than MAP2 (Mercken et al., 1995). Bearing in
mind differences in cell types as well as MAPs investigated in
other studies, we conclude that the in vivo MT
association/dissociation of ensconsin appears to be more
dynamic than that of any other MAP known to bind along the
length of MTs. 
Olmsted et al. suggested that changes in the cell cycle or
differentiation state might influence MAP:MT binding
dynamics (Olmsted et al., 1989). Certainly, changes in
phosphorylation state and MT dynamics that occur during cell
cycle progression and during differentiative events would
appear to be sufficient to change ensconsin’s MT-binding
dynamics. In untreated cells, in which ensconsin exhibits a
dynamic association with MTs, it does not appear to influence
MT dynamics (Faire et al., 1999). However, our results suggest
that ensconsin is functionally altered and may contribute to MT
stability under conditions in which it exhibits a long-lived,
rather than a transient, association with MTs. Fabré-Jonca et
al. demonstrated increased expression of ensconsin (E-MAP-
115) during epithelial differentiation; they hypothesized that
the MAP contributes to the MT stabilization that accompanies
differentiation (Fabré-Jonca et al., 1998; Fabré-Jonca et al.,
1999). This is a reasonable hypothesis, providing that
conditions extant during cell differentiation are sufficient to
slow the dynamics of the MAP’s MT association, and that its
resulting, prolonged association then contributes to MT
stability. Under in vitro conditions in which ensconsin was
tightly bound to Taxol MTs, the MAP appeared to contribute
to stabilization of these MTs against depolymerization by
calcium (Bulinski and Bossler, 1994). Whether ensconsin
stabilizes MTs in vivo when bound in its less dynamic state is
a subject for future investigation. 
Our results suggest that changes in the MTs themselves are
unlikely to explain changes in ensconsin:MT binding.
Alterations in binding dynamics more likely result from
changes in ensconsin itself. For example, it is unlikely that
changes in MT dynamics are sufficient to alter the residence
time of ensconsin on MTs, since we saw no change in speckle
dynamics in cells treated with concentrations of nocodazole
that were previously reported to dampen MT dynamics by
inhibiting assembly/disassembly at plus ends (Jordan et al.,
1992; Liao et al., 1995). In addition, ensconsin’s MT-binding
dynamics are unlikely to be responsive to the quantity of MT
polymer, since treatment with Taxol increases the level of MT
polymer in cells, while detergent extraction does not, yet both
treatments dampen the speckle dynamics of 5×GFP-EMTB.
Similarly, altered ensconsin binding is unlikely to be
attributable to changes in the MT lattice, since the lattice is
unlikely to be changed in the same way, and to different
extents, by each of the four treatments that alter ensconsin
binding. 
A reasonable hypothesis is that ensconsin:MT dynamics are
dictated, at least partially, by the MAP’s in vivo affinity for
MTs. The affinity of the ensconsin chimera, 5×GFP-EMTB,
or MTs was estimated to be roughly 40 µM (Table 3). This
value is not unexpected because it suggests that ensconsin
binds less tightly in vivo than in vitro, where its affinity was
Fig. 5.Dynamics of MAP interaction with MTs does not depend
upon their state of post-translational detyrosination. Micrographs of
fixed TC-7 cells show fluorescence of MAP chimera visualized with
GFP(a,c,e,g) and immunofluorescence of detyrosinated tubulin (anti-
Glu antibody) visualized with rhodamine secondary
antibody(b,d,f,h). Cells were treated as follows: a,b, untreated; c,d,
detergent-extracted; e,f, ATP-reduced (azide-treated); and g,h, Taxol-
treated. Note that, although there are more detyrosinated MTs in
treated cells than in untreated ones, the detyrosinated MTs constitute
only a subset of the total array under all conditions. Bar, 10 µm. 
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measured to be 1.6 µM (Bulinski and Bossler, 1994). In vitro,
ensconsin’s MT affinity resembled that reported for other
MAPs bound along the MT; in vivo affinities of other MAPs
could not be compared since only ensconsin’s KD,apphas thus
far been estimated in living cells. In vitro affinities of tau
protein and MAP4, whose MT-binding domains are highly
homologous to one another, are 0.9 µM and 1.1 µM (Butner
and Kirschner, 1991; Chapin and Bulinski, 1994). MAP2,
whose MT-binding domain is homologous to those of tau and
MAP4, shows an affinity of 5 µM for full-length MAP2 (Wallis
et al., 1993) and 1.1 µM for its MT-binding domain (Coffey
and Purich, 1995). While it is unlikely that ensconsin occupies
MT-binding sites that overlap with these other MAPs, because
ensconsin and MAP4 were shown not to compete for MT-
binding (Bulinski and Borisy, 1980), ensconsin’s intrinsic
affinity for its own MT-binding sites appears to be similar to
the binding of other MAPs to their sites. 
We hypothesized that alterations in MT-binding dynamics of
ensconsin in cells undergoing Taxol or azide treatments could
be explained by changes in the MAP’s affinity. However, we
were unable to detect a significant change in KD,app in azide-
treated cells, and in Taxol-treated cells, affinity decreased,
rather than increased (Table 3). At first glance, these results
appeared difficult to reconcile with FRAP results showing that
the Taxol and azide treatments decreased kOFF by one and two
orders of magnitude, respectively (Table 2). However, several
mechanisms are consistent with these data. Two feasible
models by which kOFF could change without a compensatory
decrease in KD,appare shown in Fig. 7. In the first, the ‘enzyme
phosphorylation model’, an enzyme promotes both MT
association and dissociation of ensconsin, and this catalyst is
regulated by a high turnover phosphorylation. The cartoon
shows that this enzyme, whose phosphorylation would be
inhibited by Taxol and azide, might normally facilitate on/off
dynamics of ensconsin by lowering the activation energy for
the ensconsin:MT binding reaction. Since the phosphorylated
enzyme is required to facilitate both reactions, inhibition of the
enzyme’s phosphorylation would change binding dynamics,
but would not change the relative quantities bound and
unbound. Thus, slower dynamics would not decrease the
KD,app.
The second model in Fig. 7, the ‘ensconsin phosphorylation
model’, couples a cycle of ensconsin phosphorylation/
dephosphorylation with the MAP’s MT binding/dissociation.
As shown in the cartoon, this model envisions that ensconsin
binds to the MT in the dephosphorylated state, followed by
phosphorylation that enhances its dissociation from the MT.
Free ensconsin’s phosphate then undergoes hydrolysis prior to
rebinding of the MAP to the MT. As shown, this model would
predict a change in KD,app, when Taxol or azide were applied.
However, KD,appwould not change if the phosphatase that acts
on ensconsin was also inhibited by azide or Taxol treatment.
In the presence of Taxol or azide, altered association of
the phosphatase with ensconsin, or failure to activate the
phosphatase by phosphorylation, are equally likely
mechanisms by which the ensconsin phosphorylation model
would allow a change in kOFF without a compensatory change
in KD,app. Further studies on ensconsin phosphorylation will be
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Fig. 6. In vivo MT-binding dynamics of GFP-
ensconsin chimeras are reduced by treatment with
staurosporine. Fluorescent speckle microscopy
(FSM) was used to record the dynamics of 5×GFP-
EMTB chimeras in living cells. (A,B,C) Time-lapse
micrographs of 5×GFP-EMTB speckles in living
cells, treated with (A) staurosporine (25 nM, 2
hours), a general inhibitor of protein kinases; (B) no
treatment; and (C) sodium azide and deoxyglucose
(5 mM and 1 mM, 30 minutes) to substantially
reduce cellular ATP. Arrows indicate speckles that
remain from one panel to the next; open, white
arrowheads denote speckles that disappear during the
time-lapse sequence; and black-filled arrowheads
denote speckles that appear during the time-lapse
sequence. Elapsed time of each exposure is shown in
seconds under each panel. (D-F) Kymographs of a
MT segment from each of the time-lapse sequences;
the scale markers on the left indicate the distance
and time over which the kymographs were made.
Kymographs and micrographs are the same
magnification. Note that treatment with
staurosporine substantially reduced dynamics of
5×GFP-EMTB speckles (A,D), in comparison with
untreated cells (B,E). 
3895In vivo dynamics of E-MAP115 (ensconsin) 
required to define and test these or other mechanisms and to
identify components responsible for changing ensconsin’s MT-
binding dynamics in vivo.
We note that each of the treatment conditions found to
change ensconsin:MT dynamics have been correlated with
changes in the phosphorylation state of cellular proteins. For
example, reduction of cellular ATP level and extraction of cells
are both known to change phosphorylation level of many
proteins, and Taxol treatment has been reported to alter the
activity and phosphorylation state of numerous proteins
(Wolfson et al., 1997; Shtil et al., 1999; Blagosklonny et al.,
1999; Yujiri et al., 1999; Stone and Chambers, 2000). Since in
our current studies we are measuring an early effect of Taxol
(2 hours) in cells that remain in interphase, we have
successfully separated those Taxol effects that are directly due
to the drug from those that result secondarily, from Taxol-
induced mitotic arrest (Ling et al., 1998). Taken together,
results of ATP-reduction, kinase inhibition, extraction, and
Taxol-treatment suggest that ensconsin may be dynamically
associated with MTs when it is constantly phosphorylated,
while its partial dephosphorylation may be sufficient to slow
its MT-binding dynamics. Ensconsin phosphorylation may be
a switch that the cell uses to regulate the dynamics of the
MAP’s association with MTs. Moreover, this switch may
regulate ensconsin’s capacity to stabilize MTs. Our studies
may help to uncover a mechanism by which the MT
cytoskeleton is reversibly stabilized in vivo. 
Although we have not yet identified molecules that interact
with the projection domain of ensconsin, it is important to
consider that any putative ensconsin-binding proteins would be
regulated in their residence time on MTs in concert with the
regulation of ensconsin. The recent identification of multi-
functional proteins containing domains of interaction for more
than one cytoskeletal filament system, such as MACF (Sun et
al., 2001) suggests the need to separately regulate the binding
to each filament system. Our studies on the regulation of
ensconsin may provide a useful paradigm for teasing out
independent regulation of binding of these multi-functional
proteins to MTs, microfilaments and intermediate filaments.
It is worth noting recent improvements in methodology that
facilitated our studies. For example, Olmsted et al. and
Scherson et al. were only able to obtain a low level of
fluorescent labeling by microinjecting fluorochrome-labeled
MAP preparations into cells (Olmsted et al., 1989; Scherson
et al., 1984). Low intensity and rapid bleaching of the
fluorescence limited their analyses to FRAP studies of specific
regions of the cell, or bundles of MTs, respectively. Our use of
GFP labeling yielded some improvement and allowed us to
analyze single MTs. However, with only a single GFP
molecule attached, the fluorescence intensity and bleaching
properties of expressed GFP-Ensc made extensive analysis of
single MTs difficult. Using the 5×GFP-EMTB construct,
containing five tandemly arrayed GFP’s attached to a single
molecule of ensconsin’s MT-binding domain was a significant
improvement that proved to be amenable to FRAP analysis
of single MTs, with a high signal-to-noise ratio. Perhaps
surprisingly, by several assays, 5×GFP-EMTB behaved
identically to the full-length MAP, confirming its use as a
reporter for ensconsin’s MT-binding behavior. 
In addition, use of the 5×GFP-EMTB construct as a reporter
of ensconsin’s MT-binding dynamics allowed us to use FSM
for rapidly examining qualitative changes in ensconsin’s MT-
binding behavior. FSM has been shown to be useful for
analysis of actin and tubulin (Waterman-Storer and Salmon,
1998; Waterman-Storer et al., 1998) and of an intriguing MAP,
CLIP-170, which associates only with the growing ends of
MTs (Perez et al., 1999). The ease of recording FSM
observations advanced our knowledge of ensconsin’s behavior,
demonstrated that its residence time on the MT could be
manipulated by experimental conditions, and identified those
conditions that should be examined via the more laborious
FRAP technique. 5×GFP-EMTB also allowed us to determine
the occupancy of ensconsin binding sites on MTs, and allowed
us to estimate, for the first time, the binding affinity of a MAP
along MTs in vivo.
Our results also bear on the mechanism by which MTs
are stabilized in detergent-extracted cytoskeletons. It was
first reported by Bershadsky and Gelfand that addition of
ATP was sufficient to depolymerize MTs in detergent-











A. Enzyme phosphorylation model
B. Ensconsin phosphorylation model
Fig. 7.Kinase activity regulates ensconsin’s MT-binding dynamics in
living cells. Two possible models by which kinase activity could
affect the dynamics of ensconsin’s association with MTs in vivo.
(A) The enzyme phosphorylation model involves a hypothetical
enzyme that, when phosphorylated, promotes both ensconsin’s
association with and dissociation from the MT. Note that this model
predicts that ATP depletion or inhibition of protein kinases would
bring about a decrease in ensconsin’s MT-binding dynamics, without
a concomitant increase in MT-binding affinity. (B) The ensconsin
phosphorylation model predicts that phosphorylation of ensconsin
that occurs while it is bound to the MT enhances its dissociation,
while dephosphorylation in the cytoplasm enhances its rebinding to
the MT. This model would predict that ATP depletion or inhibition of
protein kinases would decrease ensconsin’s MT-binding dynamics;
an increase in MT-binding affinity of ensconsin would be expected to
ensue unless the phosphatase shown was also dependent upon
phosphorylation for its activity.
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Phosphorylation of MAPs was suggested as a potential
mechanism for inducing depolymerization of the MTs in these
preparations. Our results suggest ensconsin as a candidate
MAP that may mediate the stability of extracted cytoskeletons
and allow their instability in the presence of ATP. It is notable
that detergent-extracted cytoskeletons are a frequent tool for
studying MT-based transport or endocytic processes. ATP
reduction, extraction of kinases, and cessation of MT dynamics
that accompany the preparation of these cytoskeletons are all
widely acknowledged to alter the metabolic state of
cytoskeletal preparations, relative to living cells. However, it
has not been appreciated that ensconsin, and perhaps other
molecules with similar behavior, may cause cytoskeletal
preparations to be markedly different in molecular composition
from the in vivo MT cytoskeleton that is being modeled. This
is especially worrisome, since increased amounts of other
MAPs, tau and MAP4, on in vivo MTs have been shown to
be sufficient to inhibit various MT-based transport events
(Bulinski et al., 1997; Ebneth et al., 1998). Likewise,
decreasing the koff of ensconsin binding may be sufficient to
alter transport events, rendering detergent-extracted
cytoskeletons or even some in vivo models inappropriate for
study of many transport events. Cells may even co-opt this
mechanism for regulating MT-based transport in vivo. 
APPENDIX
Relation of the FRAP recovery rate constant to the
dissociation rate constant, koff
Assuming that molecule A can bind reversibly to a spatially-
fixed site B to form a complex AB, then the reaction
equilibrium is given by
The forward reaction rate (units: M s–1) is 
ron = kon[A][B] (A2)
where kon is the bimolecular association rate constant (units:
M–1 s–1) and the reverse reaction rate (units: M s–1) is
roff = koff[AB] (A3)
where koff is the unimolecular dissociation rate constant (units:
s–1) and all the bracketed quantities are the molar
concentrations of the indicated species. At equilibrium these
two rates are equal (ron=roff) and the corresponding association
equilibrium constant, K, is defined by
where the subscript ‘e’ indicates the concentration at
equilibrium. Given the reaction in Eqn A1, the rate of
formation of AB at any arbitrary time is given by
In the FRAP experiments, we use a brief laser pulse to
photobleach the fluorescent species A when it is bound to B,
so that at time t=0, [AB] will be 0. We assume that the
photobleaching has little effect on the fluorescence of [A]
because the bleached A subunits readily leave the bleached
region by diffusion and are replaced by unbleached subunits at
an equivalent concentration. Also, it is assumed that the
amount of A that is bleached is small compared with the total
amount in the cell. Assuming that Eqn A1 has reached
equilibrium prior to the bleaching event at t=0, and that [A] and
[B] are unaffected by the bleaching process, then
[A] = [A]e and [B] = [B]e (A6)
so that by combining Eqns A4 and A6
Substituting Eqn A7 into Eqn A5, 
Assuming that [AB]=0 at t=0, then the solution to equation A8
is given by
which applies regardless of the degree of binding site saturation
at equilibrium. Therefore, given the stated assumptions, the
rate constant for FRAP recovery is identical to the dissociation
rate constant, koff.
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